You are hereRecent Publications of Members of the Boston Ithaca Islet Club / cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS-1 cells

cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS-1 cells


By JPGRAY - Posted on 24 February 2009

TitlecAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS-1 cells
Publication TypeJournal Article
Year of Publication2006
AuthorsKang G, Chepurny OG, Malester B, Rindler MJ, Rehmann H, Bos JL, Schwede F, Coetzee WA, Holz GG
JournalJ Physiol
Volume573
IssuePt 3
Pagination595-609
Date PublishedJun 15
Publication Languageeng
ISBN Number0022-3751 (Print)
Accession Number16613879
Key WordsReceptors, Rats, Potassium Channels, Membrane Potentials, Kinetics, Humans, Cell Line, Animals, Adenosine Triphosphate/*metabolism, ATP-Binding Cassette Transporters/metabolism, 8-Bromo Cyclic Adenosine Monophosphate/analogs & derivatives/pharmacology, Thionucleotides/pharmacology, Drug/metabolism, inhibitors/*metabolism, Inwardly Rectifying/antagonists &, Potassium Channels/drug effects/*metabolism, Insulin-Secreting Cells/drug effects/*metabolism, Guanine Nucleotide Exchange Factors/genetics/*metabolism, Cyclic GMP/analogs & derivatives/pharmacology, Cyclic AMP/analogs & derivatives/antagonists & inhibitors/pharmacology
Abstract

The Epac family of cAMP-regulated guanine nucleotide exchange factors (cAMPGEFs, also known as Epac1 and Epac2) mediate stimulatory actions of the second messenger cAMP on insulin secretion from pancreatic beta cells. Because Epac2 is reported to interact in vitro with the isolated nucleotide-binding fold-1 (NBF-1) of the beta-cell sulphonylurea receptor-1 (SUR1), we hypothesized that cAMP might act via Epac1 and/or Epac2 to inhibit beta-cell ATP-sensitive K+ channels (K(ATP) channels; a hetero-octomer of SUR1 and Kir6.2). If so, Epac-mediated inhibition of K(ATP) channels might explain prior reports that cAMP-elevating agents promote beta-cell depolarization, Ca2+ influx and insulin secretion. Here we report that Epac-selective cAMP analogues (2'-O-Me-cAMP; 8-pCPT-2'-O-Me-cAMP; 8-pMeOPT-2'-O-Me-cAMP), but not a cGMP analogue (2'-O-Me-cGMP), inhibit the function of K(ATP) channels in human beta cells and rat INS-1 insulin-secreting cells. Inhibition of K(ATP) channels is also observed when cAMP, itself, is administered intracellularly, whereas no such effect is observed upon administration N6-Bnz-cAMP, a cAMP analogue that activates protein kinase A (PKA) but not Epac. The inhibitory actions of Epac-selective cAMP analogues at K(ATP) channels are mimicked by a cAMP agonist (8-Bromoadenosine-3', 5'-cyclic monophosphorothioate, Sp-isomer, Sp-8-Br-cAMPS), but not a cAMP antagonist (8-Bromoadenosine-3', 5'-cyclic monophosphorothioate, Rp-isomer, Rp-8-Br-cAMPS), and are abrogated following transfection of INS-1 cells with a dominant-negative Epac1 that fails to bind cAMP. Because both Epac1 and Epac2 coimmunoprecipitate with full-length SUR1 in HEK cell lysates, such findings delineate a novel mechanism of second messenger signal transduction in which cAMP acts via Epac to modulate ion channel function, an effect measurable as the inhibition of K(ATP) channel activity in pancreatic beta cells.

Notes

R01-DK45817/DK/NIDDK NIH HHS/United StatesR01-HL064838/HL/NHLBI NIH HHS/United StatesR21-DK067283/DK/NIDDK NIH HHS/United StatesComparative StudyJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tEngland

URLhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16613879
Citation Key393
Export